1. Home
  2. EWTX vs YELP Comparison

EWTX vs YELP Comparison

Compare EWTX & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EWTX
  • YELP
  • Stock Information
  • Founded
  • EWTX 2017
  • YELP 2004
  • Country
  • EWTX United States
  • YELP United States
  • Employees
  • EWTX N/A
  • YELP N/A
  • Industry
  • EWTX Biotechnology: Pharmaceutical Preparations
  • YELP Other Consumer Services
  • Sector
  • EWTX Health Care
  • YELP Consumer Discretionary
  • Exchange
  • EWTX Nasdaq
  • YELP Nasdaq
  • Market Cap
  • EWTX 1.6B
  • YELP 2.0B
  • IPO Year
  • EWTX 2021
  • YELP 2012
  • Fundamental
  • Price
  • EWTX $15.40
  • YELP $33.41
  • Analyst Decision
  • EWTX Buy
  • YELP Hold
  • Analyst Count
  • EWTX 10
  • YELP 6
  • Target Price
  • EWTX $37.90
  • YELP $35.83
  • AVG Volume (30 Days)
  • EWTX 875.0K
  • YELP 797.2K
  • Earning Date
  • EWTX 11-06-2025
  • YELP 11-06-2025
  • Dividend Yield
  • EWTX N/A
  • YELP N/A
  • EPS Growth
  • EWTX N/A
  • YELP 16.67
  • EPS
  • EWTX N/A
  • YELP 2.19
  • Revenue
  • EWTX N/A
  • YELP $1,451,224,000.00
  • Revenue This Year
  • EWTX N/A
  • YELP $6.16
  • Revenue Next Year
  • EWTX N/A
  • YELP $3.87
  • P/E Ratio
  • EWTX N/A
  • YELP $15.25
  • Revenue Growth
  • EWTX N/A
  • YELP 5.37
  • 52 Week Low
  • EWTX $10.60
  • YELP $29.96
  • 52 Week High
  • EWTX $38.12
  • YELP $41.72
  • Technical
  • Relative Strength Index (RSI)
  • EWTX 51.61
  • YELP 57.84
  • Support Level
  • EWTX $14.88
  • YELP $32.30
  • Resistance Level
  • EWTX $16.08
  • YELP $34.00
  • Average True Range (ATR)
  • EWTX 0.85
  • YELP 0.97
  • MACD
  • EWTX -0.04
  • YELP 0.18
  • Stochastic Oscillator
  • EWTX 50.88
  • YELP 85.10

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.

Share on Social Networks: